JOHN WOODYEAR,JR: Open Payments
NPI 1124110994 · TROY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 67 payments from 17 companies in 2025. Trend: 2023 $991 · 2024 $1,068 · 2025 $1,506
Food & beverage: $1,506
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $385 |
| ABBVIE INC. | 23 | $364 |
| Lilly USA, LLC | 4 | $159 |
| Viatris Specialty LLC | 6 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Orexo US, Inc. | 4 | $82 |
| Braeburn Inc. | 3 | $50 |
| Gilead Sciences, Inc. | 2 | $47 |
| Indivior Inc. | 1 | $40 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
Products named: AIRSUPRA, BREZTRI, MAVYRET, MOUNJARO, VRAYLAR, YUPELRI, CAPLYTA, Zubsolv.
Industry payments across NC — which companies pay providers there.
